← Back to headlines
Hybio's Generic Weight-Loss Drug Awaits FDA Review
Hybio Pharmaceuticals' generic version of a weight-loss drug is reportedly slated for review by the U.S. Food and Drug Administration.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
HDFC Bank CEO Sashidhar Jagdishan to Step Down in October
42m ago
FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder
1h ago
UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings
2h ago
S&P, Nasdaq end lower after Fed Chair Warsh reaffirms inflation fight - Reuters
2h ago